Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Wouters EF, et al. Among authors: postma ds. Thorax. 2005 Jun;60(6):480-7. doi: 10.1136/thx.2004.034280. Thorax. 2005. PMID: 15923248 Free PMC article. Clinical Trial.
[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].
Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group. Wouters EF, et al. Among authors: postma ds. Rev Port Pneumol. 2005 Nov-Dec;11(6):587-9. Rev Port Pneumol. 2005. PMID: 16514718 Portuguese. No abstract available.
Predictors of COPD symptoms: does the sex of the patient matter?
Watson L, Schouten JP, Löfdahl CG, Pride NB, Laitinen LA, Postma DS; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Watson L, et al. Among authors: postma ds. Eur Respir J. 2006 Aug;28(2):311-8. doi: 10.1183/09031936.06.00055805. Epub 2006 May 17. Eur Respir J. 2006. PMID: 16707516 Free article. Clinical Trial.
Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L, Vonk JM, Löfdahl CG, Pride NB, Pauwels RA, Laitinen LA, Schouten JP, Postma DS; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Watson L, et al. Among authors: postma ds. Respir Med. 2006 Apr;100(4):746-53. doi: 10.1016/j.rmed.2005.08.004. Epub 2005 Sep 30. Respir Med. 2006. PMID: 16199147 Free article.
Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD.
Budulac SE, Postma DS, Hiemstra PS, Kunz LI, Siedlinski M, Smit HA, Vonk JM, Rutgers B, Timens W, Boezen HM; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) study group. Budulac SE, et al. Among authors: postma ds. Respir Res. 2010 May 20;11(1):60. doi: 10.1186/1465-9921-11-60. Respir Res. 2010. PMID: 20487524 Free PMC article.
897 results